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Abstract Bifidobacterium longum RD47 was cultured in
24 kinds of modified MRS broths containing various
ingredients to select the most promising source that induces
microbial enzymes. Among the various ingredients,
ascorbic acid significantly enhanced a-L-arabinofuranosi-
dase and a-L-arabinopyranosidase activities in Bifidobac-
terium longum RD47. Addition of 2 % ascorbic acid (w/v)
to MRS showed the maximum enzyme activities. Both
whole cell and disrupted cell homogenates showed efficient
q-nitrophenyl-b-D-glucopyranoside and q-nitrophenyl-b-D-
glucofuranoside hydrolysis activities. The initially
enhanced a-L-arabinopyranosidase and a-L-arabinofura-
nosidase activities by ascorbic acid were maintained over
the cell disruption process. The optimal pH of a-L-arabi-
nofuranosidase and a-L-arabinopyranosidase was 5.0 and
7.0, respectively. Both enzymes showed the maximum
activities at 40.0 C. Under the controlled condition using
Bifidobacterium longum RD47, ginsenoside Rb2, and Rc
were converted to ginsenoside Rd.
Keywords a-L-Arabinofuranosidase  a-L-
Arabinopyranosidase  Ascorbic acid  Bifidobacterium 
Bioconversion  Ginsenosides
Introduction
Panax ginseng (Panax ginseng C. A. Meyer) has been
widely regarded as an important oriental plant medicine in
East Asia since cultivation started around 11 BC (Jia and
Zhao 2009). Ginseng contains various phytochemicals such
as polyacetylenes, polyphenolic compounds, and ginseno-
sides (saponins). Among these phytochemicals, ginseno-
sides generally exhibit the pharmacological and
nutraceutical effects of ginseng (Nagai et al. 1972; Kar-
ikura et al. 1991).
Previous research has identified approximately 40 types
of ginsenosides and their quantities in ginseng (Kim et al.
1987). Ginsenosides can be divided into two main cate-
gories based on their aglycone: the protopanaxadiol groups
(Ra, Rb1, Rb2, Rb3, Rc, Rd, Rg3, F2) and the pro-
topanaxatriol groups (Re, R1, R2, Rf, Rg1, Rg2, F1, Rh1).
These two groups of ginsenosides exhibit different phar-
macological and nutraceutical effects on human health
(Sakakibara et al. 1975; Shibata et al. 1976; Odashima
et al. 1985; Toda et al. 1990; Scaglione et al. 1990; Wu
et al. 1992). Among the various ginsenosides, ginsenoside
Rd (Rd), the deglycosylated form of Rc and Rb2, has been
regarded as a key indicator for identifying the quality of
ginseng (Ye et al. 2013; Zhou et al. 2014). Several studies
recently reported the wound-healing, neuroprotective, and
anti-inflammatory uses of Rd itself (Ye et al. 2009; Wang
et al. 2012; Zhang et al. 2012; Kim et al. 2013).
As reported by Tawab et al. (2003), the conversion of
ginsenosides into deglycosylated form is crucial for its
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in vivo biological activity. Various methods (e.g., chemical
treatment, mild acid hydrolysis, and alkaline cleavage)
have been developed as ways to convert ginsenosides into
deglycosylated form (Han et al. 1982; Bae et al. 2003; Ko
et al. 2003). However, these methods produce significant
amount of by-products (e.g., epimerization, hydration, and
hydroxylation) (Chen et al. 1987; Elyakov et al. 1993; Chi
and Ji 2005; Chi et al. 2005). In order to resolve these
problems, numerous studies in both academia and industry
use probiotic enzymes to transform ginsenosides into
aglycones (e.g., Hasegawa et al. 1997; Bae et al. 2000; Ko
et al. 2000; Ko et al. 2003; Bae et al. 2004). For example,
several Korean food and pharmaceutical conglomerates
have applied for patents to achieve ginseng market domi-
nance over the last several years (Table 1). Nowadays, the
size of the Korean ginseng market is estimated to be $1.14
billion (Baeg and So 2013).
In order to convert ginsenoside Rc and/or Rb2 into Rd,
a-L-arabinofuranosidase (Abf) and a-L-arabinopyranosi-
dase (Abp) have been cloned in Escherichia coli (Lee et al.
2011; An et al. 2012). However, from a marketing and food
safety point of view, using genetically modified organism
and E. coli has practical limitations for use in the food
industry. Several studies have shown that the addition of
specific nutrients can considerably change microbial
enzyme activities; in this case, the induced enzyme can be
applied to ginsenoside conversion (Crociani et al. 1994;
Degnan and Macfarlane 1995; Salyers et al. 1977; Tzortzis
et al. 2003; Hsu et al. 2005; Ku et al. 2011).
Herein, we aim to show the optimal condition (i.e., the
concentration of ascorbic acid and ginseng extract, tem-
perature, cell disruption step, and pH) to improve Abf and
Abp activities in Bifidobacterium longum RD47 (BL47).
The induced Abf and Abp were applied to convert gin-
senoside Rb2 and Rc into Rd.
Materials and methods
Materials
Panax ginseng roots were purchased from a local grocery
store in Korea. Chiro-inositol and pinitol were provided by
Amiocogen Co., Ltd. (Korea). Acetonotrile, methanol, and
water were purchased from J. T. Baker (USA). Gin-
senoside standard Rb2, Rc, and Rd were purchased from
BTGin Co., Ltd. (Korea). Yeast extract, proteose peptone,
beef extract and deMan, Rogosa, Sharp (MRS) media were
purchased from Becton, Dickinson and Company (BD)
(USA). Glucose-free MRS was formulated according to the
manual of microbiological culture media (DifcoTM and
BBLTM Manual 2009; Ku et al. 2009, 2011). The glucose-
free MRS contained 10 g proteose peptone, 10 g beef
extract, 5 g yeast extract, 1 g polysorbate 80, 2 g ammo-
nium citrate, 5 g sodium acetate, 0.1 g magnesium sulfate,
0.05 g manganese sulfate, and 2 g dipotassium phosphate
in 1 l of distilled water. The pH of the broth was 6.5 ± 0.2
at 25 C and 2 % of agar was added if needed.
Cell growth condition
In order to select a promising nutrient for the enzyme
induction, various modified MRS broths containing dif-
ferent carbon sources were designed (Table 2). The pH of
all broths was adjusted to 7.0 via the addition of sodium
hydroxide, and all the broths were sterilized using 0.2 lm
Table 1 Intellectual properties of Korean foods and drug companies related to bioconversion of ginsenosides
Company Patent title Right
registration
Nongshim Co., Ltd. Saponin-biotransforming activity and processes for preparing fermented ginseng using the same 4 July 2013
Korean intestine-derived microorganisms having saponin-biotransforming activity and processes
for preparing fermented ginseng using the same
26 November
2010
Lotte Chilsung Fermented ginseng containing bio-conversed ginsenoside metabolites increased by co-





Korean intestine-derived microorganisms having saponin-biotransforming activity and processes
for preparing fermented ginseng using the same
26 November
2010
Woongjin Foods Co., Ltd. Novel microorganism for red ginseng fermenting, ferment solution and fermentative red ginseng
drink using the same
5 August
2013
Korea Yakult Co., Ltd. A method of preparation for fermented red ginseng using conversion by enzyme mixture and
fermentation by lactic acid bacterium and the products containing fermented red ginseng
manufactured thereof as effective factor
13 June 2014
Daesang Corp. A novel strain of kimchi lactic acid bacteria having ginsenoside Rg3 enrichment activity and
methods for preparing fermented ginseng using the strain
5 June 2014
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syringe Ersatz-Membranfilter (BRAND, Germany). After
two successive transfers in the MRS broth, 1 % (v/v) of
activated BL 47 was inoculated into each modified MRS
broth and grown anaerobically at 37 C for 18 h. The
viable cell counts were determined by plating on MRS
containing 2 % agar (BD, USA) under anaerobic condi-
tions. Cell growth rates were measured optically using a
spectrophotometer at 600 nm (Model Benchmark, Bio-
Rad, Japan) (Table 2).
Enzyme assay
Enzyme activities were measured for three different sam-
ples: whole, lysed, and disrupted cells. Whole cell sus-
pension was prepared as previously described (Park et al.
2012). Cell lysis step was carried out to extract microbial
enzyme from the whole cell using lysis solution as
described in Ku et al. (2011). Disrupted cell suspension
was prepared by the cell sonicator set at 45 amplifications
for 3 min at 4 C. For the enzyme reaction, 5 mM of q-
nitrophenyl-b-D-glucopyranoside (pNPP), and q-nitro-
phenyl-b-D-glucofuranoside (pNPF) (Sigma, St. Louis,
Mo., U.S.A.) were used. The released pNP was measured at
405 nm (Model Benchmark, Bio-Rad, Japan) after enzyme
reaction at 37 C. Enzyme activity was evaluated using the
following equation:
ln A½  A½ M¼ kt
in which A = enzyme activity of BL47 cultured at modi-
fied MRS at time t; AM = enzyme activity of BL47 cul-
tured at normal MRS; k = rate constant; and t = time
(min) (Ximenes et al. 2011).
Determination of the optimal enzyme condition
(ascorbic acid concentration, ginseng extracts
concentration, pH, cell disruption time,
and temperature)
To determine the optimal concentration of ascorbic acid,
BL47 was anaerobically grown in MRS with 0–5 % (w/v)
of ascorbic acid at 37 C for 18 h. After determination of
the optimal ascorbic acid concentration, 0–55 % (v/v) of
ginseng extracts were added to the modified MRS broth
containing 2 % ascorbic acid (w/v). The activated BL47
was inoculated to each media and anaerobically grown at
37 C. One ml (5 9 108 CFU/ml) of the cell suspension
was harvested, washed twice in PBS, and then re-sus-
pended in 4 ml of PBS at 37 C. During the cell sonication
process, enzyme activity was evaluated at 30 s interval as
described above. The degree of cell disruption was mea-
sured by the optical density at 600 nm. The optimal pH and
temperature of Abf and Abp were determined by the
aforementioned method (Ku et al. 2011).
Treatment of ginseng extracts using disrupted cell
suspension
Ginsenosides were extracted from the ginseng root using
the method described in our previous study (Kim et al.
2008). The disrupted cell suspensions from 5 9 108 CFU/
ml were mixed with the ginseng extracts at the ratio of 19:1
(v/v) and incubated at 37 C. The cell-ginseng extract
suspensions were collected after 3, 6, 9, and 12 days and
evaluate the bioconversion of ginsenosides through TLC
analysis (Park et al. 2012).
Table 2 Modified MRS broths tested in the experiment
No. Ingredient X/XM No. Ingredient X/XM No. Ingredient X/XM No. Ingredient X/XM
Glucose-free MRS ? 2 % (w/v) of nutrient
1 L-Arabinose 0.74 ± 0.05 2 Lactose 0.59 ± 0.04 3 Raffinose 0.77 ± 0.04 4 Fructose 1.35 ± 0.06
5 Glucose 0.95 ± 0.06 6 Maltose 1.13 ± 0.03 7 Sucrose 1.54 ± 0.07 8 Xylose 0.64 ± 0.02
MRS ? 2 % (w/v) of nutrient
9 L-Rhamnose 0.91 ± 0.01 10 Raffinose 0.95 ± 0.02 11 Chiro-
inositol
0.95 ± 0.01 12 Pinitol 0.89 ± 0.04
13 Fructose 1.01 ± 0.01 14 Maltose 0.92 ± 0.01 15 Sucrose 1.13 ± 0.04 16 Xylose 0.57 ± 0.04
17 Cellobiose 0.93 ± 0.02 18 Ribose 0.83 ± 0.01 19 Sucralose 0.9 ± 0.04 20 Mannose 0.87 ± 0.06
21 Lactic acid 0.61 ± 0.01 22 Glycine 0.88 ± 0.02 23 Asc-acid 1.02 ± 0.03 24 Cit-acid 0.52 ± 0.02
X/XM relative microbial growth rates in which XM growth rate at commercial MRS, X growth rate at modified MRS, Asc-acid ascorbic acid, Cit-
acid citric acid
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Addition of ginseng extracts to MRS broth
supplemented with ascorbic acid and ginsenosides
conversion
Five to 55 % (v/v) of ginseng extracts were added to
MRS ? 2 % ascorbic acid (w/v) broth. The initial pH of all
broths was adjusted to 7.0 by adding sodium hydroxide.
Activated BL 47 was anaerobically cultured at 37 C for
7 days without shaking. The whole cell and ginseng extract
suspensions were collected after 2, 3, 4, 5, 6, and 7 days to
evaluate the bioconversion of ginsenosides using the TLC
analysis (Park et al. 2012). The changed Abf and Abp
activities by the concentration of ginseng extracts were
determined using our previous method (Ku et al. 2011).
Statistical analysis
For the statistical evaluation of cell growth rates and changed
enzyme activities, the analysis of variance (ANOVA) was
applied using the programMinitab 16, and the Tukey’s test
was applied for the post hoc comparison. Significant dif-
ferences were considered at p\ 0.05.
Fig. 1 Relative enzyme
activities of Bifidobacterium
longum Rd47 cultured in the
various broths (n = 3). Cell
lysis solution was treated to
samples. Error bars standard
deviation. White bars a-
arabinofuranosidase, black bars
a-arabinopyranosidase
Fig. 2 The effect of ascorbic
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Results and discussion
Induction of Abf and Abp using ascorbic acid
In our previous work, various carbon, nitrogen, and ion
sources were added to the microbial culture broth and
determined the optimal a- and b-galactosidases production
from BL47 (Han et al. 2014). In this study, we aimed to
investigate which sources were effective inducers for the
Abf and Abp and whether any of the sources could promote
the growth of BL47 (Table 2). As sole carbon sources,
L-arabinose, lactose, and xylose (#1, 2 and 8) were inef-
fective for the growth of BL47. Fructose and maltose
showed a slight enhancement (#4 and 6). BL47 showed the
best growth when sucrose (#7) was added. There were no
statistically significant growth differences between com-
mercial MRS (control) and modified MRS containing
glucose (#5) (p\ 0.05), which demonstrates that com-
mercial MRS and lab-made MRS have a similar effect on
cell growth (Fig. 1).
Several studies have shown that the addition of certain
organic acids to culture media can improve the cell via-
bility by neutralizing hydrogen peroxide and reducing
redox potential (Brewer et al. 1977; Collins and Hall 1984;
Ku et al. 2011). Interestingly, the addition of some organic
acids to culture media modified the morphology of Bifi-
dobacterium spp. by ion chelation during fermentation
(Kojima et al. 1968, 1970; Ku et al. 2009). In this work, the
addition of 2 % (w/v) lactic acid (#21) and citric acid (#24)
to commercial MRS showed a decrease in cell viability
(p\ 0.05). However, the degrees of the BL 47 growth
were not significantly affected by the presence of ascorbic
acid (p[ 0.05), as compared to those cultured in normal
MRS (Fig. 1). The microscopic morphology of BL47 was
not changed by ascorbic acid (data not shown). Both Abf
and Abp activities of BL47 were outstandingly increased
by adding 2 % of ascorbic acid (w/v) (p\ 0.05). For fur-
ther examination of the role of ascorbic acid, 0–4 % (w/v)
of ascorbic acid was added to commercial MRS (Fig. 2).
As a result, the degree of enzyme activity increased as the
concentration of ascorbic acid increased up to 2 %. Con-
versely, BL 47 cultured in media containing 4 % of
ascorbic acid showed significantly decreased enzyme
activity (p\ 0.05) and decreased growth (p\ 0.05).
These results suggested that ascorbic acid can enhance
Abf and Abp activity and were optimal at 2 %. Because
majority of probiotic bacteria are anaerobic microorgan-
isms, it is common in the food industry to add ascorbic acid
into commercial probiotic products in order to scavenge
oxygen. Several studies have demonstrated the effects of
ascorbic acid on lactic acid bacteria (Dave and Shah 1997;
Talwalkar and Kailasapathy 2004; Santiesteban-Lo´pez
et al. 2013; Shu et al. 2013). These studies focused on
evaluating changed cell growth rates to determine best
conditions for the yield of lactic acid bacteria. The con-
centrations of ascorbic acid used in their experiments were
relatively lower (\0.1 % w/v) than in our experiment (2 %
w/v). The present study reports a newly observed
enhancement of Abf and Abp activities from the genus
Bifidobacterium by ascorbic acid.
Optimal pH, temperature, and disruption conditions
for Abf and Abp
Some microbial enzymes produced from lactic acid bac-
teria showed high enzyme activity in the acidic conditions
(Ku et al. 2011). The optimal pHs of Abp in B. breve
K-110 and B. longum H-1 were 5.8 and 6.8, respectively
(Shin et al. 2003; Lee et al. 2011). The optimal pHs of Abf
activity in B. breve K-110 and B. longum H-1 were 4.5 and
Fig. 3 The effect of cell









circles degree of cell disruption
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4.7, respectively. The maximum Abf and Abp activities of
the BL47 cultured in MRS were observed at pH 6.0 and
5.0, respectively, whereas those cultured in MRS broth
containing 2 % of ascorbic acid (w/v) were observed at pH
7.0 and 5.0 (p\ 0.05), respectively.
The maximum Abf and Abp activities were observed at
40 C for BL47 within our experimental range of 4–70 C
and about 60 % of both Abf and Abp activities were
detected after incubation at 60 C for 10 min compared to
the maximum activity (data not shown). During the cell
Fig. 4 The effect of ginseng




(n = 3). Enzyme activities were
evaluated without disruption
step. Error bars standard




Fig. 5 TLC profile of ginsenosides conversion using disrupted cell
Fig. 6 TLC profile of ginsenosides conversion using whole cell
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sonication process, the degree of cell disruption was
increased while the optical density of cell suspension was
gradually decreased at 600 nm (Fig. 3). There was no
statistically significant loss of the Abf and Abp activities
(p[ 0.05) during this process. The whole cell suspension
efficiently hydrolyzed q-nitrophenyl-b-D-glucopyranoside
and q-nitrophenyl-b-D-glucofuranoside. These results sug-
gest that both enzymes apparently have high resistance to
physical disruption.
Cell disruption process is essential to use cytosolic
enzymes for the bioconversion (Chi and Ji 2005; Chi et al.
2005; Yan et al. 2008; Noh and Oh 2009; Yoo et al. 2011).
However, these processes are time consuming and labor
intensive. In our previous work (Ku et al. 2011; Park et al.
2012), we reported successful hydrolysis of glycosides
using whole cell without cell disruption process. This
minimal microbial process may lead to cost reduction, an
important practical application in the food industry.
Bioconversion of ginsenosides
The use of microbial crude enzymes can reduce food
processing cost, as compared to the use of purified enzymes
(Singh et al. 2013). Based on the presently determined
optimal conditions [ascorbic acid concentration: 2 % (w/
v); temperature: 40 C; pH: 5], the disrupted BL 47
homogenates (5 9 108 CFU/ml) and the whole cell sus-
pension of BL 47 (5 9 108 CFU/ml) were applied to the
hydrolysis of natural substrates. Ginsenosides Rb2 and Rc
are differentiated from Rd by the presence of a-L-glu-
copyranoside and a-L-glucofuranoside, respectively;
therefore, aglycone of ginsenosides Rb2 and Rc is the same
as that of ginsenoside Rd (Shin et al. 2003). The whole cell
suspension converted both Rb2 and Rc into Rd; however,
the disrupted cell extracts only converted Rb2 to Rd. The
effect of BL47 enzymes on the experimental ginsenosides
was slightly different from its effects on pNP substrates.
This difference may be caused by the direct application of
crude enzyme homogenates (i.e., the whole cell and dis-
rupted cell suspensions) into the bioconversion step with-
out protein purification. Similar results were reported with
microorganisms Flavobacterium johnsoniae and Cla-
dosporium cladosporioides (Hong et al. 2012; Wu et al.
2012). When BL47 was cultured in modified MRS con-
taining 2 % ascorbic acid and various levels of ginseng
extracts, both Abf and Abp showed maximum activities
when the ginseng extracts were 10 % (v/v) without sig-
nificant changes in growth rate (p[ 0.05) (Fig. 4). How-
ever, the enzyme activities were gradually decreased by
adding additional ginseng extract to the broths.
During the processing step to make ginseng extracts, a
high level of carbohydrates can be extracted from ginseng
because more than 60 % of the ginseng root consists of
carbohydrates (Van et al. 2009; Choi et al. 2014). Several
studies report that the addition of a high concentration of
carbon sources to culture media decreased the induced
enzyme activity (van der Veen et al. 1994; Gielkens et al.
1999; Gueimonde et al. 2007; Hetta et al. 2014). Sa´nchez
and Hardisson (1980) hypothesized that this enzyme inhi-
bition may be the result of catabolite repression and inac-
tivation, or the reduced usability of the inducer. The TLC
profile of transformed ginsenosides by using the whole cell
suspension of BL47 showed a transformation of gin-
senoside Rc and Re to Rd. We also detected ginsenoside F2
and unknown faint bands (Figs. 5, 6).
This study revealed that the addition of 2 % of ascorbic
acid to MRS media caused a significant increase in Abf and
Abp activities of BL47. We also showed the optimal condi-
tions for the induced enzymes. Based on our results, we
applied the whole cell and disrupted cell homogenates to the
bioconversion of ginsenosides in order to use this process in
industrial applications. The bioconversion using whole and
livingcell inmedia containingginseng extracts is not perfectly
completed; however, the potential for reducing production
cost has been approved. Our protocol is more practical for the
bioconversion of ginsenosides than conventional methods,
which usually include numerous procedures (such as enzyme
purification, cell disruption, gene work). Further work in the
molecular level shouldbeconducted in order to investigate the
effect of ascorbic acid on BL 47.
Acknowledgments This work was supported by the Next-Genera-
tion BioGreen 21 Program (No. PJ009543), Rural Development
Administration, Republic of Korea. The authors wish to thank Mr.
Thomas R. Kreke, LORRE researcher at Purdue University and Dr.
Hyunyi Jung, Assistant Professor at Calvin College for their initial
reviews, and other anonymous reviewers for their feedback on this
paper.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://creati
vecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
An DS, Cui CH, Sung BH, Yang HC, Kim Sc, Lee ST, Im WT, Kim
SG (2012) Characterization of a novel ginsenoside hydrolyzing
a-L-arabinofuranosidase, AbfA, from Rhodanobacter ginseno-
sidimutans Gsoli 3054T. Appl Microbiol Biotechnol 94:673–682
Bae EA, Park SY, Kim DH (2000) Constitutive b-glucosidases
hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal
bacteria. Biol Pharm Bull 23:1481–1485
Bae EA, Kim NA, Han MJ, Choo MK, Kim DH (2003) Transfor-
mation of ginsenosides to compound K (IH-901) by lactic acid
bacteria of human intestine. J Microbiol Biotechnol 13:9–14
Bae EA, Han MJ, Kim EJ, Kim DH (2004) Transformation of ginseng
saponins to ginsenoside Rh2 by acids and human intestinal
J Korean Soc Appl Biol Chem (2015) 58(6):857–865 863
123
bacteria and biological activities of their transformants. Arch
Pharm Res 27:61–67
Baeg IH, So SH (2013) The world ginseng market and the ginseng
(Korea). J Ginseng Res 37:1–7
Brewer DG, Martin SE, Ordal ZJ (1977) Beneficial effects of catalase
or pyruvate in a most probable-number technique for the
detection of Staphylococcus aureus. Appl Environ Microbiol
34:797–800
Chen Y, Nose M, Ogihara Y (1987) Alkaline cleavage of ginsenoside.
Chem Pharm Bull (Tokyo) 35:1653–1655
Chi H, Ji GE (2005) Transformation of ginsenosides Rb1 and Re from
Panax ginseng by food microorganisms. Biotechnol Lett
27:765–771
Chi H, Kim DH, Ji GE (2005) Transformation of ginsenosides Rb2
and Rc from Panax ginseng by food microorganisms. Biol Pharm
Bull 11:2102–2105
Choi HS, Kim SY, Park Y, Jung EY, Suh HJ (2014) Enzymatic
transformation of ginsenosides in Korean Red Ginseng (Panax
ginseng Meyer) extract prepared by Spezyme and Optidex.
J Ginseng Res 38:264–269
Collins EB, Hall BJ (1984) Growth of bifidobacteria in milk and
preparation of Bifidobacterium infantis for a dietary adjunct.
J Dairy Sci 67:1376–1380
Crociani F, Alessandrini A, Mucci MM, Biavati B (1994) Degrada-
tion of complex carbohydrates by Bifidobacterium spp. Int J
Food Microbiol 24:199–210
Dave IR, Shah NP (1997) Effectiveness of ascorbic acid as an oxygen
scavenger in improving viability of probiotic bacteria in
yoghurts made with commercial starter cultures. Int Dairy J
7:435–443
Degnan BA, Macfarlane GT (1995) Arabinogalactan utilization in
continuous cultures of Bifidobacterium longum. Effect of co-
culture with Bacteroides thetaiotaomicron. Anaerobe 1:103–112
DifcoTM, BBLTM Manual (Manual of microbiological culture media),
2nd edition. (2009), http://www.bd.com/ds/technicalcenter/misc/
difcobblmanual_2nded_lowres.pdf. Accessed Jan 1 2015, 289–
90
Elyakov GB, Atopkina LN and Uvarova NI (1993) Proceedings of the
6th international Ginseng symposium Seoul, pp 74–83
Gielkens M, Gonza´lez-Candelas L, Sa´nchez-Torres P, van de
Vondervoort P, de GraaV L, Visser J, Ramo´n D (1999) The
abfB gene encoding the major a-L-arabinofuranosidase of
Aspergillus nidulans: nucleotide sequence, regulation and con-
struction of a disrupted strain. Microbiology 145:735–741
Gueimonde M, Nriega L, Margolles A, Reyes-Gavila´n CG (2007)
Induction of a-L-arabinofuranosidase activity by monomeric
carbohydrates in Bifidobacterium longum and ubiquity of
encoding genes. Arch Microbiol 187:145–153
Han BH, Park MH, Han YN, Woo LK, Sankawa U, Yahara S, Tanaka
O (1982) Degradation of ginseng saponins under mild acidic
conditions. Planta Med 44:146–149
Han YR, Youn SY, Ji GE, Park MS (2014) Production of a- and b-
galactosidases from Bifidobacterium longum subsp. longum
RD47. J Microbiol Biotechnol 24:675–682
Hasegawa H, Sung JW, Benno Y (1997) Role of human intestinal
Prevotella oris in hydrolyzing ginseng saponins. Planta Medica
63:436–440
Hetta MH, Aly HF, Ali NW (2014) Estimation of resveratrol content
in peanut pericarp and its relation to the in vitro inhibitory
activity on carbohydrate metabolizing enzymes. Die Pharm
69:92–95
Hong H, Cui CH, Kim JK, Jin FX, Kim SC, Im WT (2012) Enzymatic
biotransformation of ginsenoside Rb1 and gypenoside XVII into
ginsenosides Rd and F2 by recombinant b-glucosidase from
Flavobacterium johnsoniae. J Ginseng Res 36:418–424
Hsu CA, Yu RC, Chou CC (2005) Production of b-galactosidase by
bifidobacteria as influenced by various culture conditions. Int J
Food Microbiol 104:197–206
Jia L, Zhao Y (2009) Current evaluation of the millennium
phytomedicine-ginseng (I): etymology, pharmacognosy, phyto-
chemistry, market and regulations. Curr Med Chem
16:2475–2484
Karikura M, Miyase T, Tanizawa H, Taniyama T, Takino Y (1991)
Studies on absorption, distribution, excretion and metabolism of
ginseng saponins. VII. Comparison of the decomposition modes
of ginsenoside-Rb1 and -Rb2 in the digestive tract of rats. Chem
Pharm Bull (Tokyo) 39:2357–2361
Kim MW, Ko SR, Choi KJ, Kim SC (1987) Distribution of saponin in
various sections of Panax ginseng root and changes of its
contents according to root age. Korean J Ginseng Sci 11:10–16
Kim MS, Kwon B, Park MS, Ji GE (2008) Isolation of ginsenoside
Rh1 and compound K from fermented ginseng and efficacy
assessment on systemic anaphylactic shock. Food Sci Biotechnol
17:805–808
Kim SH, Min JW, Quan LH, Lee S, Yang DU, Yang DC (2012)
Enzymatic transformation of ginsenoside Rb1 by Lactobacillus
pentosus strain 6105 from Kimchi. J Ginseng Res 36:291–297
Kim WK, Song SY, Oh WK, Kaewsuwan S, Tran TL, Kim WS, Sung
JH (2013) Wound-healing effect of ginsenoside Rd from leaves
of Panax ginseng via cyclic AMP-dependent protein kinase
pathway. Eur J Pharmacol 702:285–293
Kojima M, Suda S, Hotta S, Hamada K (1968) Induction of
pleomorphism in Lactobacillus bifidus. J Bacteriol 95:710–711
Kojima M, Suda S, Hotta S, Hamada K (1970) Induction of
pleomorphy and calcium ion deficiency in Lactobacillus bifidus.
J Bacteriol 102:217–220
Ko SR, Suzuki Y, Choi KJ, Kim YH (2000) Enzymatic preparation of
genuine prosapogenin, 20(S)-ginsenoside Rh1 from ginsenoside
Re and Rg1. Biosci Biotechnol Biochem 64:2739–2743
Ko SR, Choi KJ, Uchida K, Suzuki Y (2003) Enzymatic preparation
of ginsenosides Rg2, Rh1, and F1 from protopanaxatriol-type
ginseng saponin mixture. Planta Medica 69:285–286
Ku S, You HJ, Ji GE (2009) Enhancement of anti-tumorigenic
polysaccharide production, adhesion, and branch formation of
Bifidobacterium bifidum BGN4 by phytic acid. Food Sci
Biotechnol 18:749–754
Ku S, Zheng H, Park MS, Ji GE (2011) Optimization of b-
glucuronidase activity from Lactobacillus delbrueckii Rh2 and
its use for biotransformation of baicalin and wogonoside.
J Korean Soc Appl Biol Chem 54:275–280
Lee JH, Hyun YJ, Kim DH (2011) Cloning and characterization of a-
L-arabinofuranosidase and bifunctional a-L arabinopyranosidase/
b-D-galactopyranosidase from Bifidobacterium longum H-1.
J Appl Microbiol 111:1097–1107
Nagai M, Ando S, Tanaka N, Tanaka O, Shibata S (1972) Chemical
studies on the oriental plant drugs. XXVIII. saponins and
sapogenins of ginseng: stereochemistry of the sapogenin of
ginsenoside Rb1, Rb2 and Rc. Chem Pharm Bull 20:1212–1216
Noh KH, Oh DK (2009) Production of the rare ginsenosides
compound K, compound Y, and compound Mc by a ther-
mostable b-glycosidase from Sulfolobus acidocaldarius. Biol
Pharm Bull 32:1830–1835
Odashima S, Ohta T, Kohno H, Matsuda T, Kitagawa I, Abe H, Arichi
S (1985) Control of phenotypic expression of cultured B16
melanoma cells by plant glycosides. Cancer Res 45:2781–2784
Park SJ, Youn SY, Ji GE, Park MS (2012) Whole cell biotransfor-
mation of major ginsenosides using Leuconostocs and Lacto-
bacilli. Food Sci Biotechnol 21:839–844
Sakakibara K, Shibata Y, Higashi T, Sanada S, Shoji J (1975) Effect
of ginseng saponins on cholesterol metabolism. I. The level and
864 J Korean Soc Appl Biol Chem (2015) 58(6):857–865
123
the synthesis of serum and liver cholesterol in rats treated with
ginsenosides. Chem Pharm Bull (Tokyo) 23:1009–1016
Salyers AA, West SEH, Vercellotti JR, Wilkins TD (1977) Fermen-
tation of plant polysaccharides by anaerobic bacteria from the
human colon. Appl Environ Microbiol 34:529–533
Sa´nchez J, Hardisson C (1980) Glucose inhibibion of galactose-
induced synthesis of beta-galactosidase in Streptomyces vio-
laceus. Arch Microbiol 125:111–114
Santiesteban-Lo´pez A, Lo´pez-Malo JJ, Gomez-Diaz B, Armendariz P
(2013) Effect of L-cysteine and ascorbic acid on the propagation
of Lactobacillus casei in milk. Int Res J Microbiol 4:113–118
Scaglione F, Ferrara F, Dugnani S, Falchi M, Santoro G, Fraschini F
(1990) Immunomodulatory effects of two extracts of Panax
ginseng C.A. Meyer. Drug Exp Clin Res 16:537–542
Shibata Y, Nozaki T, Higashi T, Sanada S, Shoji J (1976) Stimulation
of serum protein synthesis in ginsenoside treated rat. Chem
Pharm Bull (Tokyo) 24:2818–2824
Shin HY, Park SY, Sung JH, Kim DH (2003) Purification and
characterization of a-L-arabinopyranosidase and a-L-arabinofu-
ranosidase from Bifidobacterium breve K-110, a human intesti-
nal anaerobic bacterium metabolizing ginsenoside Rb2 and Rc.
Appl Environ Microbiol 69:7116–7123
Shu G, Yang Q, He C (2013) Effect of ascorbic acid and cysteine
hydrochloride on growth of Bifidobacterium bifidum. Adv J Food
Sci Technol 5:678–681
Singh A, Sharma HK, Kumar S, Upadhyay A, Mishra KP (2013)
Comparative effect of crude and commercial enzyme on the
juice recovery from bael fruit (Aegle marmelos Correa) using
principal component analysis. Int J Food Sci. doi:10.1155/2013/
239839
Talwalkar A, Kailasapathy K (2004) The role of oxygen in the
viability of probiotic bacteria with reference to L. acidophilus
and Bifidobacterium spp. Curr Issues Intest Microbiol 5:1–8
Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M
(2003) Degradation of ginsenosides in humans after oral
administration. Drug Metab Dispos 3:1065–1071
Toda S, Kimura M, Ohnishi M (1990) Induction of neutrophil
accumulation by red ginseng. J Ethnopharmacol 30:315–318
Tzortzis G, Jay AJ, Baillon MLA, Gibson GR, Rastall RA (2003)
Synthesis of a-galactooligosaccharides with a-galactosidase
from Lactobacillus reuteri of canine origin. Appl Microbiol
Biotechnol 63:286–292
van der Veen P, Arst HN Jr, Flipphi MJ, Visser J (1994) Extracellular
arabinases in Aspergillus nidulans: the effect of different cre
mutations on enzyme levels. Arch Microbiol 162:433–440
Van Q, Nayak B, Reimer M, Jones P, Fulcher R, Rempel C (2009)
Anti-inflammatory effect of Inonotus obliquus, Polygala senega
L., and Viburnum trilobum in a cell screening assay. J Ethnophar-
macol 125:487–493
Wang L, Zhang Y, Wang Z, Li S, Min G, Wang L, Chen J, Cheng J,
Wu Y (2012) Inhibitory effect of ginsenoside-Rd on car-
rageenan-induced inflammation in rats. Can J Physiol Pharmacol
90:229–236
Wu JY, Gardner BH, Murphy CI, Seals JR, Kensil CR, Recchia J,
Beltz GA, Newman GW, Newman MJ (1992) Saponin adjuvant
enhancement of antigen-specific immune responses to an
experimental HIV-1 vaccine. J Immunol 148:1519–1525
Wu L, Jin Y, Yin C, Bai L (2012) Co-transformation of Panax major
ginsenosides Rb1 and Rg1 to minor ginsenosides C-K and F1 by
Cladosporium cladosporioides. J Ind Microbiol Biotechnol
39:521–527
Ximenes E, Kim Y, Mosier N, Dien B, Ladisch M (2011)
Deactivation of cellulases by phenols. Enzyme Microb Technol
48:54–60
Yan Q, Zhou W, Li X, Feng M, Zhou P (2008) Purification method
improvement and characterization of a novel ginsenoside-
hydrolyzing b-glucosidase from Paecilomyces Bainier sp. 229.
Biosci Biotech Biochem 72:352–359
Ye R, Li N, Han J, Kong X, Cao R, Rao Z, Zhao G (2009)
Neuroprotective effects of ginsenoside Rd against oxygen–
glucose deprivation in cultured hippocampal neurons. Neurosci
Res 64:306–310
Ye R, Zhao G, Liu X (2013) Ginsenoside Rd for acute ischemic
stroke: translating from bench to bedside. Expert Rev Neurother
13:603–613
Yoo MH, Yeom SJ, Park CS, Lee KW, Oh DK (2011) Production of
aglycon protopanaxadiol via compound K by a thermostable b-
glycosidase from Pyrococcus furiosus. Appl Microbiol Biotech-
nol 89:1019–1028
Zhang C, Du F, Shi M, Ye R, Cheng H, Han J, Ma L, Cao R, Rao Z,
Zhao G (2012) Ginsenoside Rd protects neurons against
glutamate-induced excitotoxicity by inhibiting Ca2? influx. Cell
Mol Neurobiol 32:121–128
Zhou JS, Wang JF, He BR, Cui YS, Fang XY, Ni JL, Chen J, Wang
KZ (2014) Ginsenoside Rd attenuates mitochondrial permeabil-
ity transition and cytochrome c release in isolated spinal cord
mitochondria: involvement of kinase-mediated pathways. Int J
Mol Sci 15:9859–9877
J Korean Soc Appl Biol Chem (2015) 58(6):857–865 865
123
